Rank | Gene Set | Z-score |
---|---|---|
1 | COPI coating of Golgi vesicle (GO:0048205) | 8.78290332 |
2 | Golgi transport vesicle coating (GO:0048200) | 8.78290332 |
3 | protein maturation by protein folding (GO:0022417) | 6.41405773 |
4 | endocrine pancreas development (GO:0031018) | 6.07703458 |
5 | peptide hormone processing (GO:0016486) | 5.72820516 |
6 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.58891041 |
7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.47418590 |
8 | negative regulation of cell killing (GO:0031342) | 5.47418590 |
9 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 5.40116177 |
10 | COPII vesicle coating (GO:0048208) | 5.17625031 |
11 | type B pancreatic cell development (GO:0003323) | 5.16610142 |
12 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.03073304 |
13 | insulin secretion (GO:0030073) | 5.01850548 |
14 | glandular epithelial cell differentiation (GO:0002067) | 4.95612375 |
15 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.90012008 |
16 | detection of calcium ion (GO:0005513) | 4.89753627 |
17 | glandular epithelial cell development (GO:0002068) | 4.66036361 |
18 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.65564892 |
19 | positive regulation of insulin secretion (GO:0032024) | 4.54421068 |
20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.52684223 |
21 | positive regulation of nuclease activity (GO:0032075) | 4.40085847 |
22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.36466657 |
23 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.36355360 |
24 | type I interferon signaling pathway (GO:0060337) | 4.35566949 |
25 | cellular response to type I interferon (GO:0071357) | 4.35566949 |
26 | vesicle coating (GO:0006901) | 4.32126564 |
27 | response to type I interferon (GO:0034340) | 4.32086854 |
28 | protein retention in ER lumen (GO:0006621) | 4.30871128 |
29 | exocrine pancreas development (GO:0031017) | 4.30022524 |
30 | regulation of insulin secretion (GO:0050796) | 4.27718798 |
31 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.07329400 |
32 | sequestering of metal ion (GO:0051238) | 4.05427040 |
33 | regulation of nuclease activity (GO:0032069) | 3.98555222 |
34 | negative regulation of protein oligomerization (GO:0032460) | 3.98246825 |
35 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.96307258 |
36 | positive regulation of Rap GTPase activity (GO:0032854) | 3.95183505 |
37 | chemosensory behavior (GO:0007635) | 3.94606049 |
38 | ER overload response (GO:0006983) | 3.91653434 |
39 | regulation of peptide hormone secretion (GO:0090276) | 3.89818201 |
40 | regulation of peptide secretion (GO:0002791) | 3.85129766 |
41 | inner ear receptor cell development (GO:0060119) | 3.84073383 |
42 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.82156406 |
43 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.81923631 |
44 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.80633747 |
45 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.78642909 |
46 | regulation of ARF protein signal transduction (GO:0032012) | 3.78591681 |
47 | cerebellar Purkinje cell layer development (GO:0021680) | 3.77178757 |
48 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.76688802 |
49 | protein targeting to Golgi (GO:0000042) | 3.71829220 |
50 | peptide hormone secretion (GO:0030072) | 3.70161596 |
51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.70061837 |
52 | cellular response to unfolded protein (GO:0034620) | 3.67924941 |
53 | positive regulation of peptide hormone secretion (GO:0090277) | 3.67369796 |
54 | negative regulation of norepinephrine secretion (GO:0010700) | 3.64134874 |
55 | peptide secretion (GO:0002790) | 3.63973604 |
56 | positive regulation of peptide secretion (GO:0002793) | 3.61983785 |
57 | T cell migration (GO:0072678) | 3.60902740 |
58 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.59837798 |
59 | ER-nucleus signaling pathway (GO:0006984) | 3.55163472 |
60 | nitric oxide mediated signal transduction (GO:0007263) | 3.55150104 |
61 | cellular response to topologically incorrect protein (GO:0035967) | 3.54228907 |
62 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.45831282 |
63 | negative thymic T cell selection (GO:0045060) | 3.44820321 |
64 | regulation of gamma-delta T cell activation (GO:0046643) | 3.42664555 |
65 | response to interleukin-15 (GO:0070672) | 3.40596627 |
66 | signal peptide processing (GO:0006465) | 3.39903767 |
67 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.39881511 |
68 | protein localization to Golgi apparatus (GO:0034067) | 3.39434946 |
69 | cellular response to vitamin D (GO:0071305) | 3.38536050 |
70 | regulation of hormone secretion (GO:0046883) | 3.36497689 |
71 | cellular response to interleukin-15 (GO:0071350) | 3.36374855 |
72 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.35953456 |
73 | negative regulation of catecholamine secretion (GO:0033604) | 3.35710918 |
74 | toxin metabolic process (GO:0009404) | 3.35453280 |
75 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.34693363 |
76 | negative T cell selection (GO:0043383) | 3.34314976 |
77 | establishment of protein localization to Golgi (GO:0072600) | 3.32900664 |
78 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.32251125 |
79 | regulation of Rap GTPase activity (GO:0032317) | 3.30149765 |
80 | energy homeostasis (GO:0097009) | 3.27028144 |
81 | synaptic vesicle maturation (GO:0016188) | 3.26904793 |
82 | B cell receptor signaling pathway (GO:0050853) | 3.25662392 |
83 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.25480403 |
84 | tolerance induction (GO:0002507) | 3.24568124 |
85 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.24538191 |
86 | cellular response to glucagon stimulus (GO:0071377) | 3.23312506 |
87 | response to hepatocyte growth factor (GO:0035728) | 3.18424873 |
88 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.18424873 |
89 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.17997405 |
90 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.17398309 |
91 | macroautophagy (GO:0016236) | 3.15696901 |
92 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.15259105 |
93 | regulation of peptide transport (GO:0090087) | 3.14466623 |
94 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.10962374 |
95 | negative regulation of insulin secretion (GO:0046676) | 3.09019175 |
96 | relaxation of cardiac muscle (GO:0055119) | 3.07893254 |
97 | membrane repolarization during action potential (GO:0086011) | 3.07167111 |
98 | response to endoplasmic reticulum stress (GO:0034976) | 3.06429488 |
99 | response to ischemia (GO:0002931) | 3.05585749 |
100 | regulation of norepinephrine secretion (GO:0014061) | 3.05274857 |
101 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.99393835 |
102 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.99334750 |
103 | glutamate secretion (GO:0014047) | 2.98931718 |
104 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.98674113 |
105 | epithelial cell fate commitment (GO:0072148) | 2.98473735 |
106 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.98246333 |
107 | activation of protein kinase A activity (GO:0034199) | 2.96590358 |
108 | Golgi organization (GO:0007030) | 2.93582953 |
109 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.93157667 |
110 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.91856049 |
111 | inositol phosphate dephosphorylation (GO:0046855) | 2.91856049 |
112 | positive regulation of exocytosis (GO:0045921) | 2.91241069 |
113 | inositol phosphate catabolic process (GO:0071545) | 2.89678803 |
114 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.88738075 |
115 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.88738075 |
116 | modulation by symbiont of host immune response (GO:0052553) | 2.88738075 |
117 | positive regulation by symbiont of host defense response (GO:0052509) | 2.88738075 |
118 | modulation by symbiont of host defense response (GO:0052031) | 2.88738075 |
119 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.88738075 |
120 | response to unfolded protein (GO:0006986) | 2.88566684 |
121 | peptide transport (GO:0015833) | 2.86654775 |
122 | hypothalamus development (GO:0021854) | 2.86602689 |
123 | glycerophospholipid catabolic process (GO:0046475) | 2.85538551 |
124 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.83940719 |
125 | astrocyte differentiation (GO:0048708) | 2.83802901 |
126 | interferon-gamma production (GO:0032609) | 2.83753709 |
127 | positive regulation of hormone secretion (GO:0046887) | 2.83616285 |
128 | regulation of synaptic vesicle transport (GO:1902803) | 2.81925611 |
129 | cellular zinc ion homeostasis (GO:0006882) | 2.81631104 |
130 | response to hexose (GO:0009746) | 2.81535665 |
131 | negative regulation of gluconeogenesis (GO:0045721) | 2.81384704 |
132 | response to glucose (GO:0009749) | 2.80766969 |
133 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.80617025 |
134 | hormone secretion (GO:0046879) | 2.80539680 |
135 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.80307969 |
136 | regulation of extracellular matrix disassembly (GO:0010715) | 2.79887387 |
137 | peptidyl-asparagine modification (GO:0018196) | 2.79580333 |
138 | regulation of glucocorticoid secretion (GO:2000849) | 2.78694912 |
139 | response to topologically incorrect protein (GO:0035966) | 2.78233211 |
140 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.77634186 |
141 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.77243750 |
142 | negative regulation of hormone metabolic process (GO:0032351) | 2.77243750 |
143 | macrophage activation involved in immune response (GO:0002281) | 2.76257435 |
144 | regulation of beta-amyloid formation (GO:1902003) | 2.75341104 |
145 | hormone transport (GO:0009914) | 2.71461351 |
146 | thymic T cell selection (GO:0045061) | 2.68835122 |
147 | regulation of protein glycosylation (GO:0060049) | 2.67830624 |
148 | negative regulation of peptide hormone secretion (GO:0090278) | 2.67657038 |
149 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.66597996 |
150 | response to monosaccharide (GO:0034284) | 2.66005559 |
151 | energy reserve metabolic process (GO:0006112) | 2.65241799 |
152 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.65201490 |
153 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.65120402 |
154 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.65101139 |
155 | negative regulation of bone resorption (GO:0045779) | 2.64636291 |
156 | immunoglobulin mediated immune response (GO:0016064) | 2.62910251 |
157 | detection of bacterium (GO:0016045) | 2.61611635 |
158 | positive regulation of respiratory burst (GO:0060267) | 2.61336116 |
159 | positive regulation of neurotransmitter transport (GO:0051590) | 2.60548083 |
160 | synaptic vesicle exocytosis (GO:0016079) | 2.59347563 |
161 | regulation of regulatory T cell differentiation (GO:0045589) | 2.57753472 |
162 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.55157853 |
163 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.54776393 |
164 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.54023243 |
165 | positive regulation of humoral immune response (GO:0002922) | 2.53925396 |
166 | positive T cell selection (GO:0043368) | 2.53753229 |
167 | leukocyte aggregation (GO:0070486) | 2.53356492 |
168 | negative regulation of innate immune response (GO:0045824) | 2.52882550 |
169 | signal complex assembly (GO:0007172) | 2.52605230 |
170 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.52170252 |
171 | T cell selection (GO:0045058) | 2.51747218 |
172 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.51286751 |
173 | NIK/NF-kappaB signaling (GO:0038061) | 2.51122930 |
174 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.49431663 |
175 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.48588488 |
176 | nucleoside diphosphate catabolic process (GO:0009134) | 2.47590696 |
177 | RNA destabilization (GO:0050779) | 2.47473647 |
178 | negative regulation of phagocytosis (GO:0050765) | 2.47091500 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.74309066 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.91061631 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.32418897 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.92733889 |
5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.54276058 |
6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.34353899 |
7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.26049502 |
8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.71973782 |
9 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.41261257 |
10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.38553871 |
11 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.36464908 |
12 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.21073581 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.19976886 |
14 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.15720218 |
15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.15369047 |
16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.15053713 |
17 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.10361976 |
18 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.08092283 |
19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.07369144 |
20 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 2.02954430 |
21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.98727937 |
22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.94890994 |
23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.93360966 |
24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.91443008 |
25 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.88912822 |
26 | MYC_22102868_ChIP-Seq_BL_Human | 1.88029812 |
27 | MYB_26560356_Chip-Seq_TH2_Human | 1.85200832 |
28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.82214759 |
29 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.81514767 |
30 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.81355184 |
31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.78656762 |
32 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.76174130 |
33 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.75320447 |
34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74339772 |
35 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.73645778 |
36 | MYB_26560356_Chip-Seq_TH1_Human | 1.71516035 |
37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.69482427 |
38 | MAF_26560356_Chip-Seq_TH1_Human | 1.68875756 |
39 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.62099897 |
40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.59990146 |
41 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.57847280 |
42 | STAT3_23295773_ChIP-Seq_U87_Human | 1.51651508 |
43 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.51588089 |
44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.51408964 |
45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.51158905 |
46 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.49490288 |
47 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.49256930 |
48 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.48420454 |
49 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.48146292 |
50 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.47840812 |
51 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.45596290 |
52 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.45216464 |
53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42965833 |
54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40134942 |
55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.39049236 |
56 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.37681359 |
57 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37037851 |
58 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.36478448 |
59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.36063721 |
60 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.34482093 |
61 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34349066 |
62 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33424521 |
63 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.33043936 |
64 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32625149 |
65 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.31955948 |
66 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.31018176 |
67 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.29451925 |
68 | MAF_26560356_Chip-Seq_TH2_Human | 1.28293453 |
69 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.24861245 |
70 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.24861245 |
71 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.24790802 |
72 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.23898245 |
73 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23690019 |
74 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.23127732 |
75 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22791262 |
76 | AR_19668381_ChIP-Seq_PC3_Human | 1.22790194 |
77 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22157593 |
78 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.21828957 |
79 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.20524502 |
80 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20521744 |
81 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.20256948 |
82 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.19951858 |
83 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.19683373 |
84 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19147268 |
85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19097528 |
86 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17954716 |
87 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.17622105 |
88 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.16886412 |
89 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.16751815 |
90 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.15957597 |
91 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.15825915 |
92 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15536038 |
93 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.14944787 |
94 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13852918 |
95 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.12869773 |
96 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.12523099 |
97 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.11553498 |
98 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10550231 |
99 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.10107635 |
100 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.08554469 |
101 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.08308449 |
102 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08023772 |
103 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07913371 |
104 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.07911431 |
105 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.07773814 |
106 | VDR_22108803_ChIP-Seq_LS180_Human | 1.07267200 |
107 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.07180172 |
108 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04218749 |
109 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03487633 |
110 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.03229162 |
111 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02513607 |
112 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01708272 |
113 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01450630 |
114 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.01331112 |
115 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00886756 |
116 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.00878285 |
117 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.00601607 |
118 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.00215094 |
119 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.99466998 |
120 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.99353681 |
121 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.98112866 |
122 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.97840014 |
123 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97322875 |
124 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.96373416 |
125 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.94511707 |
126 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.93461179 |
127 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.92207056 |
128 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.92128885 |
129 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.91971132 |
130 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.91740829 |
131 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.91344407 |
132 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.91318510 |
133 | P300_19829295_ChIP-Seq_ESCs_Human | 0.91243793 |
134 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.90492054 |
135 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89493093 |
136 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89199017 |
137 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89165069 |
138 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.88250381 |
139 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.87992295 |
140 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87361796 |
141 | KDM2B_26808549_Chip-Seq_K562_Human | 0.86624277 |
142 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86402017 |
143 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.85783240 |
144 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85660804 |
145 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.85093807 |
146 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84996853 |
147 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84439149 |
148 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.84285902 |
149 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83879985 |
150 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.83102688 |
151 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.82896131 |
152 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82025098 |
153 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.81853929 |
154 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81331984 |
155 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.80396743 |
156 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.79749815 |
157 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.79733963 |
158 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79552329 |
159 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77179412 |
160 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.76169405 |
161 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.75814798 |
162 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.74744029 |
163 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.73814937 |
164 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73016147 |
165 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.72575357 |
166 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.72378110 |
167 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.71831026 |
168 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.71055138 |
169 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.70880685 |
170 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.68982625 |
171 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.68729781 |
172 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.68374962 |
173 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.68152051 |
174 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.67664953 |
175 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.67592294 |
176 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.66281013 |
177 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.66102148 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003283_abnormal_digestive_organ | 4.71304317 |
2 | MP0002909_abnormal_adrenal_gland | 4.63591780 |
3 | MP0002877_abnormal_melanocyte_morpholog | 4.51683804 |
4 | MP0009780_abnormal_chondrocyte_physiolo | 4.37613165 |
5 | MP0002693_abnormal_pancreas_physiology | 4.03046009 |
6 | MP0000013_abnormal_adipose_tissue | 3.68726624 |
7 | MP0004043_abnormal_pH_regulation | 3.60157718 |
8 | MP0001944_abnormal_pancreas_morphology | 3.50590691 |
9 | MP0003195_calcinosis | 3.33432422 |
10 | MP0005379_endocrine/exocrine_gland_phen | 3.25360255 |
11 | MP0010386_abnormal_urinary_bladder | 3.13117365 |
12 | MP0002837_dystrophic_cardiac_calcinosis | 3.06582577 |
13 | MP0000678_abnormal_parathyroid_gland | 3.00798653 |
14 | MP0003183_abnormal_peptide_metabolism | 3.00785684 |
15 | MP0004270_analgesia | 2.61248942 |
16 | MP0008877_abnormal_DNA_methylation | 2.42122285 |
17 | MP0000685_abnormal_immune_system | 2.30561189 |
18 | MP0005387_immune_system_phenotype | 2.29286552 |
19 | MP0001790_abnormal_immune_system | 2.29286552 |
20 | MP0001835_abnormal_antigen_presentation | 2.19776471 |
21 | MP0002078_abnormal_glucose_homeostasis | 2.19215307 |
22 | MP0003123_paternal_imprinting | 2.16139538 |
23 | MP0004859_abnormal_synaptic_plasticity | 2.14668476 |
24 | MP0003763_abnormal_thymus_physiology | 2.08859070 |
25 | MP0005220_abnormal_exocrine_pancreas | 2.08093487 |
26 | MP0005671_abnormal_response_to | 1.99287781 |
27 | MP0003724_increased_susceptibility_to | 1.95482727 |
28 | MP0001800_abnormal_humoral_immune | 1.94587425 |
29 | MP0005646_abnormal_pituitary_gland | 1.91841272 |
30 | MP0008961_abnormal_basal_metabolism | 1.84804780 |
31 | MP0003172_abnormal_lysosome_physiology | 1.82618402 |
32 | MP0000003_abnormal_adipose_tissue | 1.82504363 |
33 | MP0005000_abnormal_immune_tolerance | 1.82256922 |
34 | MP0006072_abnormal_retinal_apoptosis | 1.81797361 |
35 | MP0002234_abnormal_pharynx_morphology | 1.80015951 |
36 | MP0003122_maternal_imprinting | 1.77907654 |
37 | MP0005645_abnormal_hypothalamus_physiol | 1.69458668 |
38 | MP0006082_CNS_inflammation | 1.66814418 |
39 | MP0003303_peritoneal_inflammation | 1.65587049 |
40 | MP0004510_myositis | 1.65423172 |
41 | MP0004264_abnormal_extraembryonic_tissu | 1.64040034 |
42 | MP0003635_abnormal_synaptic_transmissio | 1.63224535 |
43 | MP0002638_abnormal_pupillary_reflex | 1.62133569 |
44 | MP0009046_muscle_twitch | 1.61629355 |
45 | MP0002723_abnormal_immune_serum | 1.59330718 |
46 | MP0001986_abnormal_taste_sensitivity | 1.58538719 |
47 | MP0001765_abnormal_ion_homeostasis | 1.57137053 |
48 | MP0003436_decreased_susceptibility_to | 1.51141195 |
49 | MP0003868_abnormal_feces_composition | 1.49560698 |
50 | MP0002420_abnormal_adaptive_immunity | 1.48045997 |
51 | MP0001819_abnormal_immune_cell | 1.44908510 |
52 | MP0002896_abnormal_bone_mineralization | 1.44682528 |
53 | MP0003953_abnormal_hormone_level | 1.37329456 |
54 | MP0002452_abnormal_antigen_presenting | 1.34424143 |
55 | MP0002734_abnormal_mechanical_nocicepti | 1.33389471 |
56 | MP0005025_abnormal_response_to | 1.32326696 |
57 | MP0009785_altered_susceptibility_to | 1.32020903 |
58 | MP0005535_abnormal_body_temperature | 1.30609880 |
59 | MP0002928_abnormal_bile_duct | 1.29503473 |
60 | MP0003045_fibrosis | 1.28689650 |
61 | MP0000462_abnormal_digestive_system | 1.27442632 |
62 | MP0004145_abnormal_muscle_electrophysio | 1.27108586 |
63 | MP0002277_abnormal_respiratory_mucosa | 1.26648241 |
64 | MP0009333_abnormal_splenocyte_physiolog | 1.24857677 |
65 | MP0003787_abnormal_imprinting | 1.24707042 |
66 | MP0003866_abnormal_defecation | 1.24597468 |
67 | MP0002166_altered_tumor_susceptibility | 1.23836295 |
68 | MP0003300_gastrointestinal_ulcer | 1.20706550 |
69 | MP0002876_abnormal_thyroid_physiology | 1.19736163 |
70 | MP0002733_abnormal_thermal_nociception | 1.19364288 |
71 | MP0002063_abnormal_learning/memory/cond | 1.19085063 |
72 | MP0002398_abnormal_bone_marrow | 1.18671488 |
73 | MP0005058_abnormal_lysosome_morphology | 1.18259286 |
74 | MP0000716_abnormal_immune_system | 1.16573724 |
75 | MP0002139_abnormal_hepatobiliary_system | 1.15219108 |
76 | MP0003879_abnormal_hair_cell | 1.15010159 |
77 | MP0002572_abnormal_emotion/affect_behav | 1.14732547 |
78 | MP0000631_abnormal_neuroendocrine_gland | 1.13485503 |
79 | MP0000703_abnormal_thymus_morphology | 1.12065642 |
80 | MP0002419_abnormal_innate_immunity | 1.06164180 |
81 | MP0003121_genomic_imprinting | 1.05579148 |
82 | MP0000689_abnormal_spleen_morphology | 1.05104208 |
83 | MP0001502_abnormal_circadian_rhythm | 1.04802258 |
84 | MP0001845_abnormal_inflammatory_respons | 1.04251898 |
85 | MP0005451_abnormal_body_composition | 1.03479923 |
86 | MP0005075_abnormal_melanosome_morpholog | 1.02509251 |
87 | MP0002272_abnormal_nervous_system | 1.01779230 |
88 | MP0008004_abnormal_stomach_pH | 1.01361583 |
89 | MP0005310_abnormal_salivary_gland | 1.00072178 |
90 | MP0003119_abnormal_digestive_system | 0.99385439 |
91 | MP0003690_abnormal_glial_cell | 0.99036848 |
92 | MP0001299_abnormal_eye_distance/ | 0.98958819 |
93 | MP0001873_stomach_inflammation | 0.98008926 |
94 | MP0002064_seizures | 0.97304056 |
95 | MP0003252_abnormal_bile_duct | 0.95322027 |
96 | MP0001970_abnormal_pain_threshold | 0.94582525 |
97 | MP0005187_abnormal_penis_morphology | 0.94370758 |
98 | MP0002405_respiratory_system_inflammati | 0.92938438 |
99 | MP0000955_abnormal_spinal_cord | 0.91346748 |
100 | MP0004381_abnormal_hair_follicle | 0.91001275 |
101 | MP0009745_abnormal_behavioral_response | 0.90302705 |
102 | MP0005375_adipose_tissue_phenotype | 0.89634259 |
103 | MP0000613_abnormal_salivary_gland | 0.89359693 |
104 | MP0005448_abnormal_energy_balance | 0.86839185 |
105 | MP0001501_abnormal_sleep_pattern | 0.85999622 |
106 | MP0002722_abnormal_immune_system | 0.85950969 |
107 | MP0002163_abnormal_gland_morphology | 0.85243540 |
108 | MP0003959_abnormal_lean_body | 0.85009124 |
109 | MP0001270_distended_abdomen | 0.84597966 |
110 | MP0010155_abnormal_intestine_physiology | 0.84233832 |
111 | MP0010234_abnormal_vibrissa_follicle | 0.83123397 |
112 | MP0002429_abnormal_blood_cell | 0.82319271 |
113 | MP0004858_abnormal_nervous_system | 0.82285474 |
114 | MP0008469_abnormal_protein_level | 0.80067343 |
115 | MP0009643_abnormal_urine_homeostasis | 0.79645794 |
116 | MP0002557_abnormal_social/conspecific_i | 0.79169083 |
117 | MP0002148_abnormal_hypersensitivity_rea | 0.79031153 |
118 | MP0003633_abnormal_nervous_system | 0.78760419 |
119 | MP0005423_abnormal_somatic_nervous | 0.78601603 |
120 | MP0001348_abnormal_lacrimal_gland | 0.77464790 |
121 | MP0003329_amyloid_beta_deposits | 0.77072395 |
122 | MP0000230_abnormal_systemic_arterial | 0.76863752 |
123 | MP0002069_abnormal_eating/drinking_beha | 0.75602402 |
124 | MP0002254_reproductive_system_inflammat | 0.74625735 |
125 | MP0004811_abnormal_neuron_physiology | 0.74365540 |
126 | MP0000639_abnormal_adrenal_gland | 0.74333203 |
127 | MP0005253_abnormal_eye_physiology | 0.73290799 |
128 | MP0002006_tumorigenesis | 0.73169095 |
129 | MP0002229_neurodegeneration | 0.72512734 |
130 | MP0001756_abnormal_urination | 0.71520830 |
131 | MP0005636_abnormal_mineral_homeostasis | 0.69437939 |
132 | MP0000681_abnormal_thyroid_gland | 0.69046331 |
133 | MP0004085_abnormal_heartbeat | 0.68539546 |
134 | MP0003880_abnormal_central_pattern | 0.68081178 |
135 | MP0005365_abnormal_bile_salt | 0.66864103 |
136 | MP0001533_abnormal_skeleton_physiology | 0.66802006 |
137 | MP0008569_lethality_at_weaning | 0.66379314 |
138 | MP0010329_abnormal_lipoprotein_level | 0.65791624 |
139 | MP0001664_abnormal_digestion | 0.64641047 |
140 | MP0005257_abnormal_intraocular_pressure | 0.64334989 |
141 | MP0000538_abnormal_urinary_bladder | 0.63823943 |
142 | MP0004036_abnormal_muscle_relaxation | 0.62374455 |
143 | MP0002168_other_aberrant_phenotype | 0.60867819 |
144 | MP0002067_abnormal_sensory_capabilities | 0.60479425 |
145 | MP0001486_abnormal_startle_reflex | 0.59447103 |
146 | MP0005670_abnormal_white_adipose | 0.58902212 |
147 | MP0003634_abnormal_glial_cell | 0.58026956 |
148 | MP0002138_abnormal_hepatobiliary_system | 0.57790093 |
149 | MP0002066_abnormal_motor_capabilities/c | 0.56513337 |
150 | MP0002184_abnormal_innervation | 0.55531733 |
151 | MP0001666_abnormal_nutrient_absorption | 0.55392527 |
152 | MP0004924_abnormal_behavior | 0.54964412 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 7.95506664 |
2 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 6.87653341 |
3 | Hypoglycemic seizures (HP:0002173) | 6.80546840 |
4 | Symptomatic seizures (HP:0011145) | 6.02390619 |
5 | Hypoglycemic coma (HP:0001325) | 5.67744533 |
6 | Insulin-resistant diabetes mellitus (HP:0000831) | 5.26226305 |
7 | Pancreatic islet-cell hyperplasia (HP:0004510) | 5.18424280 |
8 | Abnormality of endocrine pancreas physiology (HP:0012093) | 5.06632014 |
9 | Abnormality of the pancreatic islet cells (HP:0006476) | 5.06632014 |
10 | Hyperglycemia (HP:0003074) | 4.95530372 |
11 | Large for gestational age (HP:0001520) | 4.72647017 |
12 | Ketoacidosis (HP:0001993) | 4.56937779 |
13 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.48435700 |
14 | Decreased circulating renin level (HP:0003351) | 4.08977323 |
15 | Late onset (HP:0003584) | 3.96669407 |
16 | Stomatitis (HP:0010280) | 3.96184265 |
17 | Mucopolysacchariduria (HP:0008155) | 3.67534093 |
18 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.67534093 |
19 | Dysostosis multiplex (HP:0000943) | 3.60642278 |
20 | Eczematoid dermatitis (HP:0000976) | 3.58189638 |
21 | Abnormal pancreas size (HP:0012094) | 3.42212129 |
22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.38862999 |
23 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.38862999 |
24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.38862999 |
25 | Papilledema (HP:0001085) | 3.35072273 |
26 | Visual hallucinations (HP:0002367) | 3.34505014 |
27 | Hypokalemia (HP:0002900) | 3.30920042 |
28 | EEG with generalized epileptiform discharges (HP:0011198) | 3.10667844 |
29 | Agitation (HP:0000713) | 3.10011212 |
30 | Gastrointestinal stroma tumor (HP:0100723) | 3.07975358 |
31 | Epileptiform EEG discharges (HP:0011182) | 3.06039202 |
32 | Hypsarrhythmia (HP:0002521) | 3.03661064 |
33 | Episodic fever (HP:0001954) | 3.01697479 |
34 | Unilateral renal agenesis (HP:0000122) | 3.00775094 |
35 | Abnormality of renin-angiotensin system (HP:0000847) | 2.92884982 |
36 | Retinal atrophy (HP:0001105) | 2.90991005 |
37 | Hyperparathyroidism (HP:0000843) | 2.90906255 |
38 | Recurrent sinusitis (HP:0011108) | 2.86937117 |
39 | Insulin resistance (HP:0000855) | 2.84419047 |
40 | Prominent metopic ridge (HP:0005487) | 2.84164611 |
41 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.83486597 |
42 | Testicular neoplasm (HP:0010788) | 2.82079360 |
43 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.79436291 |
44 | Conjugated hyperbilirubinemia (HP:0002908) | 2.77056457 |
45 | Increased circulating renin level (HP:0000848) | 2.76098253 |
46 | Abnormality of potassium homeostasis (HP:0011042) | 2.72777925 |
47 | Abnormality of macrophages (HP:0004311) | 2.71762937 |
48 | Hypomagnesemia (HP:0002917) | 2.68021987 |
49 | Lymphopenia (HP:0001888) | 2.67962885 |
50 | Generalized aminoaciduria (HP:0002909) | 2.66893280 |
51 | Menstrual irregularities (HP:0000858) | 2.66222678 |
52 | Vasculitis (HP:0002633) | 2.65197230 |
53 | Enlarged penis (HP:0000040) | 2.63148745 |
54 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.62313650 |
55 | Osteomalacia (HP:0002749) | 2.56866016 |
56 | Increased CSF protein (HP:0002922) | 2.56040314 |
57 | Recurrent fungal infections (HP:0002841) | 2.49294709 |
58 | Abnormality of the metopic suture (HP:0005556) | 2.47269721 |
59 | Meningitis (HP:0001287) | 2.46190511 |
60 | Recurrent bacterial skin infections (HP:0005406) | 2.45120209 |
61 | Ketosis (HP:0001946) | 2.42239455 |
62 | Hyperkalemia (HP:0002153) | 2.41346310 |
63 | Recurrent cutaneous fungal infections (HP:0011370) | 2.38743499 |
64 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.38743499 |
65 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.34230188 |
66 | Dysautonomia (HP:0002459) | 2.33291164 |
67 | Recurrent bronchitis (HP:0002837) | 2.30518984 |
68 | Global brain atrophy (HP:0002283) | 2.29702917 |
69 | Abnormality of the intrinsic pathway (HP:0010989) | 2.28941994 |
70 | Hematochezia (HP:0002573) | 2.27177997 |
71 | Recurrent abscess formation (HP:0002722) | 2.27046961 |
72 | Retrobulbar optic neuritis (HP:0100654) | 2.26381528 |
73 | Optic neuritis (HP:0100653) | 2.26381528 |
74 | Hyperphosphatemia (HP:0002905) | 2.25220840 |
75 | Type I diabetes mellitus (HP:0100651) | 2.22925525 |
76 | Increased IgE level (HP:0003212) | 2.19956167 |
77 | Pheochromocytoma (HP:0002666) | 2.19934020 |
78 | Hyperthyroidism (HP:0000836) | 2.15994961 |
79 | Hyperactive renin-angiotensin system (HP:0000841) | 2.15863493 |
80 | Myositis (HP:0100614) | 2.14270948 |
81 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.11683587 |
82 | Macroorchidism (HP:0000053) | 2.11183948 |
83 | Hypercortisolism (HP:0001578) | 2.11068850 |
84 | Inflammation of the large intestine (HP:0002037) | 2.10110171 |
85 | Recurrent skin infections (HP:0001581) | 2.09285855 |
86 | Hypochromic microcytic anemia (HP:0004840) | 2.08304662 |
87 | Mediastinal lymphadenopathy (HP:0100721) | 2.08082210 |
88 | Orchitis (HP:0100796) | 2.06855644 |
89 | Progressive neurologic deterioration (HP:0002344) | 2.06591926 |
90 | Congenital glaucoma (HP:0001087) | 2.06027867 |
91 | Cortical visual impairment (HP:0100704) | 2.05596750 |
92 | Sex reversal (HP:0012245) | 2.03872777 |
93 | Abnormal sex determination (HP:0012244) | 2.03872777 |
94 | Hypothermia (HP:0002045) | 2.03607503 |
95 | Hypotension (HP:0002615) | 2.03562074 |
96 | Gastrointestinal inflammation (HP:0004386) | 2.03438494 |
97 | Chronic diarrhea (HP:0002028) | 2.02887925 |
98 | Neoplasm of the adrenal cortex (HP:0100641) | 1.99777394 |
99 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.99390949 |
100 | Exocrine pancreatic insufficiency (HP:0001738) | 1.97079774 |
101 | Intention tremor (HP:0002080) | 1.96119299 |
102 | Abnormality of T cell physiology (HP:0011840) | 1.95737176 |
103 | Agammaglobulinemia (HP:0004432) | 1.95081522 |
104 | Abnormality of magnesium homeostasis (HP:0004921) | 1.92735816 |
105 | Progressive cerebellar ataxia (HP:0002073) | 1.92065813 |
106 | Chronic otitis media (HP:0000389) | 1.90849715 |
107 | Panhypogammaglobulinemia (HP:0003139) | 1.90795906 |
108 | Depression (HP:0000716) | 1.90795399 |
109 | Restlessness (HP:0000711) | 1.90776127 |
110 | IgM deficiency (HP:0002850) | 1.90495861 |
111 | Abdominal distention (HP:0003270) | 1.90479696 |
112 | Focal motor seizures (HP:0011153) | 1.90104708 |
113 | Recurrent viral infections (HP:0004429) | 1.89521392 |
114 | Acne (HP:0001061) | 1.87142856 |
115 | Thoracolumbar scoliosis (HP:0002944) | 1.86433784 |
116 | Type II lissencephaly (HP:0007260) | 1.86306391 |
117 | Gastrointestinal infarctions (HP:0005244) | 1.86238068 |
118 | Failure to thrive in infancy (HP:0001531) | 1.83522951 |
119 | Acute hepatic failure (HP:0006554) | 1.82612426 |
120 | Neuroendocrine neoplasm (HP:0100634) | 1.82244456 |
121 | Abnormality of T cells (HP:0002843) | 1.81298815 |
122 | Papilloma (HP:0012740) | 1.80539369 |
123 | Verrucae (HP:0200043) | 1.80539369 |
124 | Hypophosphatemia (HP:0002148) | 1.80419564 |
125 | Diplopia (HP:0000651) | 1.80083058 |
126 | Abnormality of binocular vision (HP:0011514) | 1.80083058 |
127 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.79971758 |
128 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.79971758 |
129 | Abnormality of glycolipid metabolism (HP:0010969) | 1.79971758 |
130 | Chronic bronchitis (HP:0004469) | 1.78013589 |
131 | Supranuclear gaze palsy (HP:0000605) | 1.77910876 |
132 | Pulmonary infiltrates (HP:0002113) | 1.76724116 |
133 | Anxiety (HP:0000739) | 1.75122899 |
134 | Cerebral inclusion bodies (HP:0100314) | 1.74776733 |
135 | Limb hypertonia (HP:0002509) | 1.74508199 |
136 | Impaired smooth pursuit (HP:0007772) | 1.73685019 |
137 | Premature loss of primary teeth (HP:0006323) | 1.73163411 |
138 | Resting tremor (HP:0002322) | 1.72215776 |
139 | Atonic seizures (HP:0010819) | 1.70332147 |
140 | Adrenal overactivity (HP:0002717) | 1.69391084 |
141 | Gout (HP:0001997) | 1.69047147 |
142 | Severe short stature (HP:0003510) | 1.68306319 |
143 | Hyperphosphaturia (HP:0003109) | 1.67731822 |
144 | Muscular hypotonia of the trunk (HP:0008936) | 1.67721693 |
145 | Absence seizures (HP:0002121) | 1.66475901 |
146 | Skin nodule (HP:0200036) | 1.66415858 |
147 | Protuberant abdomen (HP:0001538) | 1.64409476 |
148 | Neurofibrillary tangles (HP:0002185) | 1.63878229 |
149 | Villous atrophy (HP:0011473) | 1.63304076 |
150 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.63304076 |
151 | Intestinal atresia (HP:0011100) | 1.62973238 |
152 | Bundle branch block (HP:0011710) | 1.61687438 |
153 | Generalized hyperpigmentation (HP:0007440) | 1.59914430 |
154 | Glucose intolerance (HP:0000833) | 1.56030483 |
155 | Epileptic encephalopathy (HP:0200134) | 1.55906267 |
156 | Generalized tonic-clonic seizures (HP:0002069) | 1.55864115 |
157 | Hypokalemic alkalosis (HP:0001949) | 1.54289458 |
158 | Postural tremor (HP:0002174) | 1.54159662 |
159 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.53812544 |
160 | Hypoplasia of the fovea (HP:0007750) | 1.53812544 |
161 | Abnormal biliary tract morphology (HP:0012440) | 1.53311390 |
Rank | Gene Set | Z-score |
---|---|---|
1 | INSRR | 6.86613013 |
2 | MAPK15 | 4.84297563 |
3 | PASK | 4.67611626 |
4 | TAOK3 | 4.32893266 |
5 | PRKD3 | 3.67991920 |
6 | MAP4K1 | 3.22521986 |
7 | NTRK3 | 2.92720517 |
8 | MAP3K2 | 2.92412340 |
9 | FGFR3 | 2.84426270 |
10 | HIPK2 | 2.76649027 |
11 | PRPF4B | 2.73463092 |
12 | FGFR4 | 2.53298381 |
13 | FGFR2 | 2.49885218 |
14 | FRK | 2.46506676 |
15 | UHMK1 | 2.19215365 |
16 | SCYL2 | 2.04306078 |
17 | TYK2 | 2.02897794 |
18 | CAMKK2 | 2.01412530 |
19 | TNK2 | 1.99761651 |
20 | MAP3K1 | 1.95217321 |
21 | NTRK1 | 1.93115158 |
22 | IKBKE | 1.92788403 |
23 | WNK3 | 1.75071024 |
24 | WNK4 | 1.60785101 |
25 | IRAK4 | 1.59944622 |
26 | PRKCH | 1.47503885 |
27 | SIK2 | 1.45695561 |
28 | NLK | 1.45032541 |
29 | PDGFRA | 1.42229567 |
30 | CDC42BPA | 1.39419547 |
31 | FES | 1.37541508 |
32 | FLT3 | 1.36256344 |
33 | ERN1 | 1.32784119 |
34 | TAOK1 | 1.26290207 |
35 | TXK | 1.23765729 |
36 | MAP3K9 | 1.15316800 |
37 | SYK | 1.10788606 |
38 | CAMKK1 | 1.10702307 |
39 | BTK | 1.10219809 |
40 | KSR2 | 1.10175492 |
41 | EPHB1 | 1.10161328 |
42 | PTK2 | 1.08993824 |
43 | PRKD2 | 1.08721871 |
44 | MAP3K4 | 1.06416860 |
45 | JAK3 | 1.05993152 |
46 | PAK3 | 1.00917077 |
47 | SIK3 | 0.98035862 |
48 | MAP2K6 | 0.96627484 |
49 | MAP3K14 | 0.96319304 |
50 | IRAK1 | 0.96273416 |
51 | PTK6 | 0.95136237 |
52 | CSK | 0.93972717 |
53 | IRAK3 | 0.93381136 |
54 | IKBKB | 0.90835071 |
55 | MAPK11 | 0.90580991 |
56 | HCK | 0.89919918 |
57 | CDK19 | 0.87961765 |
58 | PRKCQ | 0.87655578 |
59 | TRIB3 | 0.87614344 |
60 | GRK5 | 0.85616083 |
61 | AKT3 | 0.85380838 |
62 | BRSK2 | 0.85106303 |
63 | RET | 0.84531615 |
64 | DAPK2 | 0.83183306 |
65 | WNK1 | 0.82306756 |
66 | EPHA4 | 0.81104435 |
67 | CDK5 | 0.80473528 |
68 | BLK | 0.78844219 |
69 | PIK3CG | 0.77998196 |
70 | ARAF | 0.76078370 |
71 | GRK6 | 0.75592391 |
72 | TBK1 | 0.72884773 |
73 | PAK6 | 0.72380510 |
74 | LYN | 0.70426667 |
75 | LCK | 0.70315615 |
76 | DYRK1B | 0.69711587 |
77 | CAMK2D | 0.68770556 |
78 | YES1 | 0.67903623 |
79 | CHUK | 0.67158114 |
80 | MARK2 | 0.67011522 |
81 | KIT | 0.66335632 |
82 | FER | 0.65894372 |
83 | CAMK2B | 0.64779483 |
84 | PTK2B | 0.63820305 |
85 | PRKCE | 0.63766163 |
86 | PNCK | 0.63120242 |
87 | MAP3K7 | 0.63055530 |
88 | RIPK1 | 0.62569554 |
89 | RIPK4 | 0.61303104 |
90 | STK24 | 0.58329942 |
91 | BRAF | 0.57487645 |
92 | JAK2 | 0.56772655 |
93 | BMPR2 | 0.56417650 |
94 | PRKCG | 0.56086858 |
95 | EPHA3 | 0.55476021 |
96 | PRKAA1 | 0.55012545 |
97 | MINK1 | 0.54842746 |
98 | EIF2AK3 | 0.54386579 |
99 | MAP2K7 | 0.54110875 |
100 | MET | 0.54070342 |
101 | BRD4 | 0.51961955 |
102 | SGK223 | 0.50732229 |
103 | SGK494 | 0.50732229 |
104 | MAPK12 | 0.50721720 |
105 | ZAP70 | 0.50458781 |
106 | MAP2K2 | 0.49481685 |
107 | DAPK1 | 0.49105533 |
108 | CAMK1G | 0.48942366 |
109 | MAPK7 | 0.48730492 |
110 | PRKD1 | 0.47853705 |
111 | PRKCZ | 0.47836844 |
112 | SGK3 | 0.47753771 |
113 | ALK | 0.47525003 |
114 | IRAK2 | 0.47427605 |
115 | SGK2 | 0.47269514 |
116 | ADRBK2 | 0.45236344 |
117 | PINK1 | 0.43788315 |
118 | BRSK1 | 0.42802740 |
119 | MARK1 | 0.42650719 |
120 | DYRK1A | 0.42493784 |
121 | CAMK2A | 0.41235423 |
122 | PDPK1 | 0.40660971 |
123 | CSF1R | 0.40013071 |
124 | MARK3 | 0.39552244 |
125 | PRKACG | 0.39443402 |
126 | PHKG1 | 0.39164903 |
127 | PHKG2 | 0.39164903 |
128 | CDK12 | 0.39104865 |
129 | PDGFRB | 0.37659654 |
130 | CSNK1A1 | 0.36684494 |
131 | SGK1 | 0.36269058 |
132 | MAP2K4 | 0.35909956 |
133 | PRKCI | 0.35529832 |
134 | RPS6KA2 | 0.34286449 |
135 | PRKACA | 0.33780272 |
136 | MAPK10 | 0.31060445 |
137 | SIK1 | 0.30816856 |
138 | JAK1 | 0.29967730 |
139 | PDK1 | 0.29892959 |
140 | NEK6 | 0.29519844 |
141 | RPS6KB1 | 0.29503351 |
142 | * RPS6KA3 | 0.29366807 |
143 | STK11 | 0.28881792 |
144 | MAP2K1 | 0.28735042 |
145 | ITK | 0.27146756 |
146 | STK38 | 0.26521317 |
147 | CAMK1 | 0.25940032 |
148 | MAP3K13 | 0.24542279 |
149 | MAPK14 | 0.23403819 |
150 | NTRK2 | 0.23303649 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 7.69651077 |
2 | Insulin secretion_Homo sapiens_hsa04911 | 3.69625190 |
3 | Protein export_Homo sapiens_hsa03060 | 3.58275846 |
4 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.78256538 |
5 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.57238986 |
6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.36287082 |
7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.33226075 |
8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.17458353 |
9 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.93603587 |
10 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.91051230 |
11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.84704816 |
12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.82001079 |
13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.80179214 |
14 | Allograft rejection_Homo sapiens_hsa05330 | 1.80040914 |
15 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.78239335 |
16 | Long-term potentiation_Homo sapiens_hsa04720 | 1.76707710 |
17 | Cocaine addiction_Homo sapiens_hsa05030 | 1.76682153 |
18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.69716649 |
19 | Taste transduction_Homo sapiens_hsa04742 | 1.67146173 |
20 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.60042463 |
21 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.59767893 |
22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.58595214 |
23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.56395248 |
24 | Circadian entrainment_Homo sapiens_hsa04713 | 1.52814357 |
25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.52711672 |
26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.50876126 |
27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.48435805 |
28 | GABAergic synapse_Homo sapiens_hsa04727 | 1.43655774 |
29 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.41587092 |
30 | Measles_Homo sapiens_hsa05162 | 1.39620704 |
31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.36460376 |
32 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.27843074 |
33 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.25691853 |
34 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.22389043 |
35 | Lysosome_Homo sapiens_hsa04142 | 1.21646584 |
36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.18422789 |
37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.18089921 |
38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.15907719 |
39 | Morphine addiction_Homo sapiens_hsa05032 | 1.15737483 |
40 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.15441418 |
41 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.15345695 |
42 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.14474670 |
43 | Circadian rhythm_Homo sapiens_hsa04710 | 1.13592174 |
44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.13447197 |
45 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.12303430 |
46 | Leishmaniasis_Homo sapiens_hsa05140 | 1.10591005 |
47 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.09852791 |
48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08260610 |
49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.07536507 |
50 | Renin secretion_Homo sapiens_hsa04924 | 1.06041038 |
51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.04726305 |
52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03573498 |
53 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.02798292 |
54 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00838480 |
55 | Influenza A_Homo sapiens_hsa05164 | 0.97740880 |
56 | Tuberculosis_Homo sapiens_hsa05152 | 0.97694392 |
57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95122674 |
58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94775958 |
59 | Hepatitis C_Homo sapiens_hsa05160 | 0.94205506 |
60 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.94169139 |
61 | Prion diseases_Homo sapiens_hsa05020 | 0.92215542 |
62 | Insulin resistance_Homo sapiens_hsa04931 | 0.92096568 |
63 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.91857017 |
64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90369440 |
65 | Salivary secretion_Homo sapiens_hsa04970 | 0.89998057 |
66 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.87381559 |
67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87169951 |
68 | Olfactory transduction_Homo sapiens_hsa04740 | 0.85316831 |
69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84738880 |
70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84374115 |
71 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.84062558 |
72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82850321 |
73 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.81617443 |
74 | Nicotine addiction_Homo sapiens_hsa05033 | 0.80212351 |
75 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.79494007 |
76 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79100797 |
77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79011305 |
78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77924864 |
79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.76455477 |
80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74937102 |
81 | Long-term depression_Homo sapiens_hsa04730 | 0.73524448 |
82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72882129 |
83 | Asthma_Homo sapiens_hsa05310 | 0.71856455 |
84 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70939457 |
85 | ABC transporters_Homo sapiens_hsa02010 | 0.68994819 |
86 | Gap junction_Homo sapiens_hsa04540 | 0.68292390 |
87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68201258 |
88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66528116 |
89 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.66126775 |
90 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65955626 |
91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65429043 |
92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.64320726 |
93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63688292 |
94 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.63590927 |
95 | Hepatitis B_Homo sapiens_hsa05161 | 0.62970132 |
96 | Melanogenesis_Homo sapiens_hsa04916 | 0.62909276 |
97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62305493 |
98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62007051 |
99 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60830967 |
100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58320000 |
101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57879095 |
102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55650954 |
103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54124243 |
104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53227340 |
105 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.51816715 |
106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50911354 |
107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50907811 |
108 | Glioma_Homo sapiens_hsa05214 | 0.50896279 |
109 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.50408104 |
110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47999435 |
111 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.47334127 |
112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43971055 |
113 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.42490541 |
114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42067228 |
115 | Alcoholism_Homo sapiens_hsa05034 | 0.41710713 |
116 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.40490013 |
117 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.40419613 |
118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38691795 |
119 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38052569 |
120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.36898936 |
121 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.32846562 |
122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.32479433 |
123 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31673089 |
124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30030772 |
125 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.29739978 |
126 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.29071763 |
127 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27364550 |
128 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.27180775 |
129 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.26600183 |
130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26310398 |
131 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.26160573 |
132 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.26074338 |
133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25559782 |
134 | Thyroid cancer_Homo sapiens_hsa05216 | 0.23988812 |
135 | Bladder cancer_Homo sapiens_hsa05219 | 0.23570438 |
136 | Prostate cancer_Homo sapiens_hsa05215 | 0.22677398 |
137 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20034682 |
138 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20019565 |